Literature DB >> 8624252

Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients.

C M Jones1, R A Lake, J B Wijeyekoon, D M Mitchell, R M du Bois, R E O'Hehir.   

Abstract

The T-cell antigen receptor (TCR) repertoire was examined in lymphocytes isolated from the lungs and blood of 12 sarcoidosis patients and nine control patients. This analysis, by polymerase chain reaction (PCR), examined the variable (V)-domain genes of both the alpha and beta chains of the TCR. This is the first study to examine the usage of all known V alpha gene segments in sarcoidosis. A similar degree of diversity was observed in the TCR repertoire in the lungs and blood of the sarcoidosis patients. However, 11 of the 12 sarcoidosis patients showed an increased use of particular TCR V alpha and V beta genes in lung T cells as compared with blood. The pattern of TCR V gene bias in the lung T cells was specific for each patient. The clonality of selected V genes was examined by determining the third complementarity-determining region (CDR3) length polymorphism of particular PCR products. The majority of lung T cells with biased TCR V gene segments were oligoclonal. Altogether, these results suggest oligoclonal expansion of lung T cells in response to a local antigenic stimulus, with additional nonspecific T-cell accumulation. The variability in the V gene segments used by the expanded T-cell subsets in different sarcoidosis patients may reflect different epitopes or antigens being recognized in the lung, as well as variations in major histocompatibility complex (MHC) haplotype between the patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624252     DOI: 10.1165/ajrcmb.14.5.8624252

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire.

Authors:  M Mempel; B Flageul; F Suarez; C Ronet; L Dubertret; P Kourilsky; G Gachelin; P Musette
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Cellular immunity in osteoarthritis: novel concepts for an old disease.

Authors:  S N Liossis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

3.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 4.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

5.  Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis.

Authors:  N Shimizudani; H Murata; H Keino; S Kojo; H Nakamura; Y Morishima; T Sakamoto; M Ohtsuka; K Sekisawa; M Sumida; T Sumida; T Matsuoka
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

6.  Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells.

Authors:  J Carlisle; W Evans; R Hajizadeh; M Nadaf; B Shepherd; R D Ott; K Richter; W Drake
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

7.  T cell receptor (TCR) Vbeta gene usage in bronchoalveolar lavage and peripheral blood T cells from asthmatic and normal subjects.

Authors:  E Hodges; J Dasmahapatra; J L Smith; C T Quin; S Lanham; M T Krishna; S T Holgate; A J Frew
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.